Electromed, Inc. (AMEX: ELMD) is a Healthcare company (Medical - Devices) with a market capitalization of $189M. The Maz Rating grades it against the other companies in its sector.
Electromed, Inc.'s current Maz Rating and its five factor grades are for members: log in to see them.
At $23.13, Electromed, Inc. trades at 16.0x trailing earnings, 2.5x sales and 3.7x book value, with an EV/EBITDA of 11.0. Over the last twelve months it generated about $76M of revenue and $12M of net income. It runs a gross margin of 79.0%, an operating margin of 19.5% and a net margin of 15.8%. It shows return on equity of 23.7%, return on invested capital of 21.4% and a free cash flow yield of 5.0%. On the balance sheet: a debt-to-equity ratio of 0.00 and a current ratio of 7.19. Over the past 52 weeks the share price ranged from $22.67 to $47.40, with a beta of 0.43.
Electromed, Inc. does not currently pay a dividend.
5 Wall Street analyst ratings cover the stock: 5 Buy, for a Buy consensus. This is the sell side's view, separate from the Maz Rating.
Figures are trailing twelve months unless stated. The Maz Rating and Maz Dividend Score rank a company against its own sector; they are not price targets or recommendations.